Explore evidence

2.3 %Plasmodium malariae was detected in 2.3% of afebrile people in Côte d'Ivoire.

Côte d'Ivoirepaludismepublished 2021Travel medicine and infectious diseasePubMeddocument of 25 observations

23 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 23% had never been exposed to HBV.

Côte d'Ivoirehépatite B · VIH/sidapublished 2010Antiviral therapyeurope_pmcdocument of 7 observations

9.7 %Three (9.7%) HIV-2 patients switched to an integrase inhibitor-based regimen.

Côte d'IvoireVIH/sidapublished 2020PloS oneeurope_pmcdocument of 13 observationsDOI 10.1371/journal.pone.0236642

2 %The SC genotype represented 2% of the samples.

Côte d'Ivoirehemoglobinobserved 2022HAL · Unilimdocument of 23 observations

25.7 %Among 1825 HIV-2-infected individuals initiating antiretroviral therapy, 469 (25.7%) were lost to follow-up over the first 24 months.

Côte d'IvoireVIH/sidapublished 2016AIDS (London, England)europe_pmcdocument of 6 observations

5.9 %At month 36, 5.9% of the patients had died.

Côte d'IvoireVIH/sidapublished 2018HIV/AIDS (Auckland, N.Z.)europe_pmcdocument of 7 observations

465 cells/mm3Patients in the immediate group had a median CD4 count of 465 cells/mm3 at baseline.

Côte d'IvoireVIH/sidapublished 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument of 8 observations

7.2 %Of 457 participants included in this study, 33 (7.2%) had unsuccessful tuberculosis treatment.

Côte d'Ivoiretuberculosepublished 2025BMC infectious diseaseseurope_pmcdocument of 9 observations

29.7 %Among individuals who slept under an LLIN the night before the survey, malaria prevalence was 29.7%.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

9.3 %Among the 943 inmates screened at the Correctional and Detention Facility of Abidjan, 88 (9.3%) met the TB case definition.

Côte d'Ivoiretuberculoseobserved 2015published 2017PloS oneeurope_pmcdocument of 8 observations

46 %For adults living with HIV, AIDS-related illnesses were the leading cause of hospital admission, accounting for 46% of admissions.

Côte d'IvoireAIDS-related illnessespublished 2015The lancet. HIVeurope_pmcdocument of 8 observations

45 %Plasma HIV-1 RNA load was elevated (≥ 5 log₁₀ copies/mL) in 45% of 491 patients.

Côte d'IvoireVIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations

14.5 %HPV vaccination uptake among adolescents girls living with HIV (AGLHIV) in Côte d'Ivoire was 14.5% for those aged 9–10 years, 16.0% for those aged 11–14 years, and 14.0% for those aged 15–19 years in the COVADOCY study conducted in 2025.

Côte d'Ivoireinfection à HPVobserved 2025HAL · Unilimdocument of 69 observations

2.4 %A seropositivity to HIV1 and/or HIV2 was observed in 32 (2.4%) of 1,334 healthy subjects of the general population from 5 different areas in Ivory Coast from January to December 1987.

Côte d'IvoireHIV1 and/or HIV2observed 1987published 1989PubMedOpenAlexdocument of 10 observations

48 patients48 patients (77.4%) were undergoing chemoprophylaxis with cotrimoxazole.

Côte d'IvoireVIH/sidaobserved 1999–2006published 2010Le Mali medicaleurope_pmcdocument of 17 observations

73 %The survival analysis showed a probability of remaining alive and in care of 73.0% after 72 months.

Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations

2,583 individualsThe study included 2583 SCD patients and healthy controls aged 5–21 years old in Mali, Senegal, Cameroon, Gabon and the Ivory Coast.

Cameroun · Côte d'Ivoire · Gabon · Mali · Sénégaldrépanocytosepublished 2019British journal of haematologyeurope_pmcdocument of 6 observations

45 yearsThe median age of HIV-2-infected individuals initiating antiretroviral therapy was 45 years.

Côte d'IvoireVIH/sidapublished 2016AIDS (London, England)europe_pmcdocument of 6 observations

24.1 %Among males, malaria prevalence was 24.1%.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

3 %Dual-type HIV (type 1 plus type 2) was found in 3% of 491 adult HIV patients.

Côte d'IvoireVIH/sidaobserved 2006published 2012World journal of hepatologyeurope_pmcdocument of 13 observations

80.7 %The survival analysis showed a probability of remaining alive and in care of 80.7% after 48 months.

Côte d'IvoireVIH/sidapublished 2025PloS oneeurope_pmcdocument of 12 observations

88 %QFT-GIT sensitivity for active TB was 88.0%.

Côte d'Ivoiretuberculosepublished 2014PloS oneeurope_pmcdocument of 8 observations

42 %Among ART-naive HIV-1-infected adults in Côte d'Ivoire, 42% had isolated anti-HBc.

Côte d'Ivoirehépatite B · VIH/sidapublished 2010Antiviral therapyeurope_pmcdocument of 7 observations

16.1 %After 24 months of follow-up, 5 out of 31 patients (16.1%) relapsed.

Côte d'Ivoireméningite cryptococciquepublished 2025IJID regionseurope_pmcdocument of 11 observations

7 %At month 6, 7% of HIV-1-infected adults on zidovudine + lamivudine + efavirenz had abnormal transaminase value.

Côte d'IvoireVIH/sidaobserved month 6published 2006Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument of 9 observationsDOI 10.1097/01.qai.0000219777.04927.50